Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns (Children ' Adults)- Protocol MW2008-09-03

Trial Profile

Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns (Children ' Adults)- Protocol MW2008-09-03

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Bromelains (Primary)
  • Indications Burns
  • Focus Adverse reactions
  • Sponsors MediWound
  • Most Recent Events

    • 09 Feb 2017 According to a MediWound media release, data from this phase II (PK) study and PK data in large burns obtained from the ongoing DETECT study will intend to support a request to FDA and EMA to extend the label for NexoBrid (Bromelains) to larger burns.
    • 06 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 26 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top